KLH 1A
Latest Information Update: 30 May 2001
At a glance
- Originator Nonindustrial sources
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 17 Apr 1997 No-Development-Reported for Cancer in Netherlands (Unknown route)
- 20 Feb 1995 Preclinical development for Cancer in Netherlands (Unknown route)